Oncogenic properties of the mutated forms of fibroblast growth factor receptor 3b-Reference-Cited by-同舟云学术

Oncogenic properties of the mutated forms of fibroblast growth factor receptor 3b

Published:2005-12-07 Issue:4 Volume:27 Page:740-747
ISSN:1460-2180
Container-title:Carcinogenesis
language:en
Short-container-title:

Author:

Bernard-Pierrot Isabelle,Brams Aude,Dunois-Lardé Claire,Caillault Aurélie,Diez de Medina Sixtina Gil,Cappellen David,Graff Gabriel,Thiery Jean Paul,Chopin Dominique,Ricol David,Radvanyi François

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Link

http://academic.oup.com/carcin/article-pdf/27/4/740/7090211/bgi290.pdf

Reference38 articles.

1. Friesel,R.E. and Maciag,T. ( 1995 ) Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J. , 9 , 919 –925.

2. Johnson,D.E. and Williams,L.T. ( 1993 ) Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res. , 60 , 1 –41.

3. Grose,R. and Dickson,C. ( 2005 ) Fibroblast growth factor signaling in tumorigenesis. Cytokine Growth Factor Rev. , 16 , 179 –186.

4. Ornitz,D.M. and Marie,P.J. ( 2002 ) FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev. , 16 , 1446 –1465.

5. Eswarakumar,V.P., Lax,I. and Schlessinger,J. ( 2005 ) Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. , 16 , 139 –149.

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FGFR3 alterations in bladder cancer: Sensitivity and resistance to targeted therapies;Cancer Communications;2024-08-19

2. The roles of FGFR3 and c-MYC in urothelial bladder cancer;Discover Oncology;2024-07-20

3. Ipsilateral synchronous papillary renal neoplasm with reverse polarity and urothelial carcinoma in a renal transplant recipient: a rare case report with molecular analysis and literature review;Diagnostic Pathology;2023-11-03

4. FGFR3 mutation characterization identifies prognostic and immune-related gene signatures in bladder cancer;Computers in Biology and Medicine;2023-08

5. Mutation S249C of FGFR3b Promotes Bladder Cancer through Downstream Signaling Proteins FRS2 and FRS3: A Computational Approach;Current Signal Transduction Therapy;2023-07